MSH|^~\&|LAB|RCH|||202003201449||ORU^R01|4188664|D|2.3|||AL|NE
PID|1||RC00007229|RC7037|LABTEST^ALMONDTHINS^||20130120|F||||||||||RC000622/19|9875495454
OBR|1|40784^LAB|00030738^2003:H00002R^LAB^200320:H2^40784|210.0690^MONO^Monotest^^^5213-4||202003201143|202003201136|||||||202003201136||||||||||LAB|D||||
NTE|1||UCI V19.2 Scenario 7a
OBX|1|ST|210.0700^MONO R^Monotest^^5213-4^5213-4|1|Negative^^N||Negative|N||A^S|D|||202003201208

MSH|^~\&|LAB|RCH|||202003201449||ORU^R01|4188665|D|2.3|||AL|NE
PID|1||RC00007229|RC7037|LABTEST^ALMONDTHINS^||20130120|F||||||||||RC000622/19|9875495454
OBR|1|40785^LAB|00030738^2003:C00004R^LAB^200320:C4^40785|500.1500^CP4^Chem 4 - Lytes^^^24326-1||202003201143|202003201136|||||||202003201136||||||||||LAB|D||||
NTE|1||UCI V19.2 Scenario 7a
OBX|1|ST|500.1900^NA^Sodium^^2951-2^2951-2|1|130^^Y|mmol/L|135-145|L||A^S|D|||202003201209
OBX|2|ST|500.2000^K^Potassium^^2823-3^2823-3|1|5.0^^Y|mmol/L|3.5-5.0|N||A^S|D|||202003201209
OBX|3|ST|500.2100^CL^Chloride^^2075-0^2075-0|1|110^^Y|mmol/L|98-108|H||A^S|D|||202003201209
OBX|4|ST|500.2200^BICARB^Bicarbonate^^1962-0^1962-0|1|20^^Y|mmol/L|20-30|N||A^S|D|||202003201209
OBX|5|ST|500.2300^GAP^Anion Gap^^33037-3^33037-3|1|0^^Y|mmol/L|3-16|L||A^S|D|||202003201209
OBR|2|40785^LAB|00030738^2003:C00004R^LAB^200320:C4^40785|520.4200^IRON^Iron Studies Profile^^^50190-8||202003201143|202003201136|||||||202003201136||||||||||LAB|D||||
NTE|1||UCI V19.2 Scenario 7a
OBX|1|ST|520.4300^FE^Iron^^14798-3^14798-3|1|40^^Y|umol/L|9-30|H||A^S|D|||202003201209
OBX|2|ST|520.4500^TIBC^Total Iron Binding Capacity^^14800-7^14800-7|1|75^^Y|umol/L|45-70|H||A^S|D|||202003201209
OBX|3|ST|520.4600^TRFSAT^Transferrin Saturation^^6796-7^14801-5|1|0.53^^Y||0.15-0.55|N||A^S|D|||202003201209
NTE|1||High transferrin saturation, suggest repeat for confirmation
NTE|2||and if it remains >0.45, followup as per BCMA/MSP protocol
NTE|3||for Iron Overload.

MSH|^~\&|MIC|RCH|||202003201449||ORU^R01|4188666|D|2.3|||AL|NE
PID|1||RC00007229|RC7037|LABTEST^ALMONDTHINS^||20130120|F||||||||||RC000622/19|9875495454
OBR|1|40786^MIC|00030738^20:M0000108R^MIC^20:M108^40786|450.5000^TS^Throat - Strep/Routine^^^626-2||202003201143|202003201136|||||||202003201136|Strep Screen/Routine^^^|||||||||MB|D||||
NTE|1||UCI V19.2 Scenario 7a
OBX|1|CE|450.5000^TS^Throat - Strep/Routine^^^626-2^O:SGA|1.1|SGA^Group A streptococcus||||||F|||202003201213
OBX|2|ST|450.5000^TS^Throat - Strep/Routine^^^626-2^P:AMT|1.1|||||||F|||202003201213
OBX|3|ST|450.5000^TS^Throat - Strep/Routine^^^626-2^R:I|1.1|Isolated||||||F|||202003201213
OBR|2||00030738^20:M0000108R^MIC^20:M108^40786|920.0100^SSBH^Strep BH Sens  SERO SUSEPT^^^50546-1||202003201143|202003201136|||||||202003201136|Strep Screen/Routine^^^|||||||||MB|D|TS^1.1|||40786^MIC
OBX|1|ST|400.200^E^Erythromycin^^233-7^234-5|||||S|||F|||202003201213
OBX|2|ST|400.300^CD^Clindamycin^^193-3^194-1|||||S|||F|||202003201213
OBX|3|ST|600.000^TS^Trimethoprim/sulfamethoxazole^^516-5^517-3|||||S|||F|||202003201213
OBX|4|ST|900.100^LZD^Linezolid^^29254-0^29255-7|||||S|||F|||202003201213

MSH|^~\&|LAB|RCH|||202003201449||ORU^R01|4188667|D|2.3|||AL|NE
PID|1||RC00007229|RC7037|LABTEST^ALMONDTHINS^||20130120|F||||||||||RC000928/18|9875495454
OBR|1|40784^LAB|00030764^2003:H00002R^LAB^200320:H2^40784|210.0690^MONO^Monotest^^^5213-4||202003201143|202003201136|||||||202003201136||||||||||LAB|F||||
NTE|1||UCI V19.2 Scenario 7a
OBX|1|ST|210.0700^MONO R^Monotest^^5213-4^5213-4|1|Negative^^N||Negative|N||A^S|F|||202003201208

MSH|^~\&|LAB|RCH|||202003201449||ORU^R01|4188668|D|2.3|||AL|NE
PID|1||RC00007229|RC7037|LABTEST^ALMONDTHINS^||20130120|F||||||||||RC000928/18|9875495454
OBR|1|40785^LAB|00030764^2003:C00004R^LAB^200320:C4^40785|500.1500^CP4^Chem 4 - Lytes^^^24326-1||202003201143|202003201136|||||||202003201136||||||||||LAB|F||||
NTE|1||UCI V19.2 Scenario 7a
OBX|1|ST|500.1900^NA^Sodium^^2951-2^2951-2|1|130^^Y|mmol/L|135-145|L||A^S|F|||202003201209
OBX|2|ST|500.2000^K^Potassium^^2823-3^2823-3|1|5.0^^Y|mmol/L|3.5-5.0|N||A^S|F|||202003201209
OBX|3|ST|500.2100^CL^Chloride^^2075-0^2075-0|1|110^^Y|mmol/L|98-108|H||A^S|F|||202003201209
OBX|4|ST|500.2200^BICARB^Bicarbonate^^1962-0^1962-0|1|20^^Y|mmol/L|20-30|N||A^S|F|||202003201209
OBX|5|ST|500.2300^GAP^Anion Gap^^33037-3^33037-3|1|0^^Y|mmol/L|3-16|L||A^S|F|||202003201209
OBR|2|40785^LAB|00030764^2003:C00004R^LAB^200320:C4^40785|520.4200^IRON^Iron Studies Profile^^^50190-8||202003201143|202003201136|||||||202003201136||||||||||LAB|F||||
NTE|1||UCI V19.2 Scenario 7a
OBX|1|ST|520.4300^FE^Iron^^14798-3^14798-3|1|40^^Y|umol/L|9-30|H||A^S|F|||202003201209
OBX|2|ST|520.4500^TIBC^Total Iron Binding Capacity^^14800-7^14800-7|1|75^^Y|umol/L|45-70|H||A^S|F|||202003201209
OBX|3|ST|520.4600^TRFSAT^Transferrin Saturation^^6796-7^14801-5|1|0.53^^Y||0.15-0.55|N||A^S|F|||202003201209
NTE|1||High transferrin saturation, suggest repeat for confirmation
NTE|2||and if it remains >0.45, followup as per BCMA/MSP protocol
NTE|3||for Iron Overload.

MSH|^~\&|MIC|RCH|||202003201449||ORU^R01|4188669|D|2.3|||AL|NE
PID|1||RC00007229|RC7037|LABTEST^ALMONDTHINS^||20130120|F||||||||||RC000928/18|9875495454
OBR|1|40786^MIC|00030764^20:M0000108R^MIC^20:M108^40786|450.5000^TS^Throat - Strep/Routine^^^626-2||202003201143|202003201136|||||||202003201136|Strep Screen/Routine^^^|||||||||MB|F||||
NTE|1||UCI V19.2 Scenario 7a
OBX|1|CE|450.5000^TS^Throat - Strep/Routine^^^626-2^O:SGA|1.1|SGA^Group A streptococcus||||||F|||202003201213
OBX|2|ST|450.5000^TS^Throat - Strep/Routine^^^626-2^P:AMT|1.1|||||||F|||202003201213
OBX|3|ST|450.5000^TS^Throat - Strep/Routine^^^626-2^R:I|1.1|Isolated||||||F|||202003201213
OBR|2||00030764^20:M0000108R^MIC^20:M108^40786|920.0100^SSBH^Strep BH Sens  SERO SUSEPT^^^50546-1||202003201143|202003201136|||||||202003201136|Strep Screen/Routine^^^|||||||||MB|F|TS^1.1|||40786^MIC
OBX|1|ST|400.200^E^Erythromycin^^233-7^234-5|||||S|||F|||202003201213
OBX|2|ST|400.300^CD^Clindamycin^^193-3^194-1|||||S|||F|||202003201213
OBX|3|ST|600.000^TS^Trimethoprim/sulfamethoxazole^^516-5^517-3|||||S|||F|||202003201213
OBX|4|ST|900.100^LZD^Linezolid^^29254-0^29255-7|||||S|||F|||202003201213